Lyme Disease (Lyme Borreliosis) is caught from bites by ticks found in forests and grassland. Diagnosed cases have risen tenfold to an estimated 3000/year in Scotland and more than 65,000/year in Europe. The disease causes substantial losses in productivity, with increasing economic and social cost.
LymeApp, a product offering an integrated set of phone app and web-based products, has been established to meet the needs of multiple customer groups effected by and dealing with increasing levels of Lyme Borreliosis (LB). The product provides maps indicating disease risk in a user’s location and provides medical advice which, when combined, helps customers avoid catching the disease and mitigate its effects if bitten.
LymeApp consists of two components: a webapp and a mobile app. The website is comprised of a user interface communicating with a server – no download of software is required with content is visualised using web mapping. The Mobile App provides basic information on ticks and LB and a basic tick map which allows all users to report tick sightings. The advanced app provides detailed information on ticks and LB and a detailed tick map. The app interacts with existing components on the mobile device. The app requests permission to access location data using the GNSS receiver built-in to modern phones. The app provides preventative advice for the risk posed by each location.
The LymeApp system is an interactive data gathering, synthesis, analysis and interrogative map generating system that incorporates quality-assured advice from national public health authorities for the better management of Lyme Borreliosis and the prevention of tick bites. LymeApp supports behavioural change and stimulates responsible health prevention management.
These products offer access to accurate and regularly updated risk maps and high quality advice. Businesses can use LymeApp for compliance with occupational health targets; healthcare providers can involve patients and public to engage with the interactivity function of LymeApp to encourage self-management.
Development of LymeApp officially commenced.
Testing Phase begins
Testing commences, including internal system testing and pilot user testing.
Testing Phase complete
Testing phase complete with feedback from pilot users evaluated.
Final review of product performed.
LymeApp expected to be made available to all.
1. How do I access LymeApp?
Once released, LymeApp will be available:
- On the Google PlayStore
- On the Apple App Store
- Through your web browser
2. When will LymeApp be available?
At the time of writing (July 2020), LymeApp is in development.
LymeApp is expected to be available for download/access in early 2021.
3. How much will LymeApp cost?
At this time, a pricing structure for LymeApp has not been confirmed.
As part of the development cycle, we will be taking feedback during the user testing phase to help decide this.
4. How can I get involved with the project?
To be kept informed on LymeApp updates and availability, please consider subscribing to our LymeApp product newsletter.